Related Experiment Video
Updated: May 31, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Progressive acute kidney injury following myocardial infarction: cholesterol embolisation
1Timmins & District Hospital, Medicine, Suite E, 640 Ross Ave. East, Timmins, Ontario, P4N 8P2, Canada.
Insights
Acute kidney injury after heart attacks has many causes. This case highlights an unusual presentation of atheroembolic renal disease, possibly triggered by blood-thinning medications.
Area of Science:
- Nephrology
- Cardiology
- Vascular Medicine
Background:
- Acute kidney injury (AKI) is a common complication following acute coronary events.
- Multiple factors contribute to AKI, including hemodynamic instability, nephrotoxic medications, and contrast agents.
- Atheroembolism is a recognized, though less common, cause of renal disease, often linked to vascular interventions.
Purpose of the Study:
- To discuss an uncommon presentation of atheroembolic renal disease.
- To explore potential triggers for atheroembolism in the context of acute coronary events.
- To highlight the role of thrombolytics and anticoagulation in precipitating atheroembolic renal disease.
Main Methods:
- Case report presentation.
- Review of clinical history and diagnostic findings.
- Discussion of potential etiological factors.
Main Results:
- The patient presented with acute kidney injury following an acute coronary event.
- Atheroembolic renal disease was diagnosed.
- The condition was potentially precipitated by thrombolytic therapy and/or anticoagulation.
Conclusions:
- Atheroembolic renal disease can present atypically following acute coronary events.
- Thrombolytic and anticoagulant therapies may precipitate atheroembolism in susceptible individuals.
- Recognition of this association is crucial for appropriate patient management and prevention of further renal damage.
Abstract:
Acute kidney injury following acute coronary event can occur from multiple factors, including secondary to volume depletion, poor perfusion because of cardiac dysfunction, secondary to medications such as angiotensin converting enzyme inhibitors or angiotensin receptor blockers or because of aggressive diuretics or use of contrast agents. Atheroembolism (cholesterol embolisation) often occurs following an intervention, such as angiography or revascularisation procedure. An uncommon presentation of atheroembolic renal disease that likely was precipitated by the use of thrombolytics and/or anticoagulation is discussed.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury III: Clinical Manifestations

